# Lubiprostone for Treatment of Chronic Idiopathic Constipation

> **NCT02695719** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 156 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** Placebo
- **DRUG:** Lubiprostone

## Key facts

- **NCT ID:** NCT02695719
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-14
- **Primary completion:** 2017-01-20
- **Final completion:** 2017-02-24
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02695719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02695719, "Lubiprostone for Treatment of Chronic Idiopathic Constipation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02695719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*